Weighted Average Number of Shares Outstanding, Basic of CRESCENT BIOPHARMA, INC. from 31 Dec 2012 to 31 Mar 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
CRESCENT BIOPHARMA, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2012 to 31 Mar 2025.
  • CRESCENT BIOPHARMA, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Mar 2025 was 64,522,257, a 0.1% increase year-over-year.
  • CRESCENT BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 64,477,249, a 1.8% increase from 2023.
  • CRESCENT BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 63,342,465, a 21% increase from 2022.
  • CRESCENT BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 52,531,173, a 2.1% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

CRESCENT BIOPHARMA, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 64,522,257 +65,024 +0.1% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 64,477,249 +1,134,784 +1.8% 01 Oct 2024 31 Dec 2024 10-K 13 Feb 2025 2024 FY
Q3 2024 64,483,958 +134,249 +0.21% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 64,483,848 +207,664 +0.32% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 64,457,233 +4,107,106 +6.8% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 63,342,465 +10,811,292 +21% 01 Oct 2023 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q3 2023 64,349,709 +11,925,765 +23% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 64,276,184 +11,868,837 +23% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 60,350,127 +8,018,736 +15% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 52,531,173 +1,077,969 +2.1% 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 52,423,944 +859,270 +1.7% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023 2023 Q3
Q2 2022 52,407,347 +868,337 +1.7% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 52,331,391 +1,634,208 +3.2% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q4 2021 51,453,204 01 Oct 2021 31 Dec 2021 10-K 27 Mar 2024 2023 FY
Q3 2021 51,564,674 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 51,539,010 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 50,697,183 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022 2022 Q1
Q2 2016 19,793,202 +781,242 +4.1% 01 Apr 2016 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q3 2015 19,025,623 +131,789 +0.7% 01 Jul 2015 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 19,011,960 +204,285 +1.1% 01 Apr 2015 30 Jun 2015 10-Q 04 Aug 2016 2016 Q2
Q4 2014 18,452,252 01 Oct 2014 31 Dec 2014 10-K 16 Mar 2015 2014 FY
Q3 2014 18,893,834 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015 2015 Q3
Q2 2014 18,807,675 +17,861,312 +1887% 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015 2015 Q2
Q1 2014 17,232,566 +16,302,037 +1752% 01 Jan 2014 31 Mar 2014 10-Q 09 May 2014 2014 Q1
Q2 2013 946,363 01 Apr 2013 30 Jun 2013 10-Q 31 Jul 2014 2014 Q2
Q1 2013 930,529 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014 2014 Q1

CRESCENT BIOPHARMA, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 64,477,249 +1,134,784 +1.8% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2025 2024 FY
2023 63,342,465 +10,811,292 +21% 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2025 2024 FY
2022 52,531,173 +1,077,969 +2.1% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
2021 51,453,204 +5,732,065 +13% 01 Jan 2021 31 Dec 2021 10-K 27 Mar 2024 2023 FY
2020 45,721,139 +2,466,357 +5.7% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2023 2022 FY
2019 43,254,782 01 Jan 2019 31 Dec 2019 10-K 03 Mar 2022 2021 FY
2014 18,452,252 +17,256,090 +1443% 01 Jan 2014 31 Dec 2014 10-K 16 Mar 2015 2014 FY
2013 1,196,162 +266,543 +29% 01 Jan 2013 31 Dec 2013 10-K 16 Mar 2015 2014 FY
2012 929,619 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.